Assessment of absolute Tc-99m tetrofosmin retention in the myocardium as an index of myocardial blood flow and coronary flow reserve by gated-SPECT/CT: a feasibility study

详细信息    查看全文

• 作者：Dimitris J. Apostolopoulos ; Agaristi Kaspiri…
• 关键词：Myocardial blood flow ; Coronary flow reserve ; SPECT/CT ; Tetrofosmin
• 刊名：Annals of Nuclear Medicine
• 出版年：2015
• 出版时间：August 2015
• 年：2015
• 卷：29
• 期：7
• 页码：588-602
• 全文大小：2,157 KB
• 参考文献：1.Schindler TH, Schelbert HR, Quercioli A, Dilsizian V. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc Imaging. 2010;3:623-0.PubMed View Article
  2.Saraste A, Kajander S, Han C, Nesterov SV, Knuuti J. PET: is myocardial flow quantification a clinical reality? J Nucl Cardiol. 2012;19:1044-9.PubMed View Article
  3.Berman DS, Germano G, Slomka PJ. Improvement in PET myocardial perfusion image quality and quantification with flurpiridaz F 18. J Nucl Cardiol. 2012;19(Suppl 1):S38-5.PubMed View Article
  4.Hajjiri MM, Leavitt MB, Zheng H, Spooner AE, Fischman AJ, Gewirtz H. Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. JACC Cardiovasc Imaging. 2009;2:751-.PubMed View Article
  5.Fiechter M, Ghadri JR, Gebhard C, Fuchs TA, Pazhenkotti AP, Nkoulou RN, et al. Diagnostic value of 13N-ammonia myocardial perfusion PET: added value of myocardial flow reserve. J Nucl Med. 2012;53:1230-.PubMed View Article
  6.Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35:1101-1.PubMed Central PubMed View Article
  7.Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009;54:150-.PubMed View Article
  8.Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow BJ, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011;58:740-.PubMed View Article
  9.Brunken RC. Challenges for measurement of myocardial perfusion and perfusion reserve by SPECT imaging. J Nucl Cardiol. 2007;14:145-.PubMed View Article
  10.Taki J, Fujino S, Nakajima K, Matsunari I, Okazaki H, Saga T, et al. (99m)Tc-sestamibi retention characteristics during pharmacologic hyperemia in human myocardium: comparison with coronary flow reserve measured by Doppler flowire. J Nucl Med. 2001;42:1457-3.PubMed
  11.Sugihara H, Yonekura Y, Kataoka K, Fukai D, Kitamura N, Taniguchi Y. Estimation of coronary flow reserve with the use of dynamic planar and SPECT images of Tc-99m tetrofosmin. J Nucl Cardiol. 2001;8:575-.PubMed View Article
  12.Ito Y, Katoh C, Noriyasu K, Kuge Y, Furuyama H, Morita K, et al. Estimation of myocardial blood flow and myocardial flow reserve by 99mTc-sestamibi imaging: comparison with the results of [15O]H2O PET. Eur J Nucl Med Mol Imaging. 2003;30:281-.PubMed View Article
  13.Storto G, Cirillo P, Vicario ML, Pellegrino T, Sorrentino AR, Petretta M, et al. Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: comparison with the results of intracoronary Doppler technique. J Nucl Cardiol. 2004;11:682-.PubMed View Article
  14.Vicario ML, Cirillo L, Storto G, Pellegrino T, Ragone N, Fontanella L, et al. Influence of risk factors on coronary flow reserve in patients with 1-vessel coronary artery disease. J Nucl Med. 2005;46:1438-3.PubMed
  15.Pellegrino T, Storto G, Filardi PP, Sorrentino AR, Silvestro A, Petretta M, et al. Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripheral artery disease. J Nucl Med. 2005;46:1997-002.PubMed
  16.Storto G, Pellegrino T, Sorrentino AR, Luongo L, Petretta M, Cuocolo A. Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries. J Nucl Cardiol. 2007;14:194-.PubMed View Article
  17.Storto G, Sorrentino AR, Pellegrino T, Liuzzi R, Petretta M, Cuocolo A. Assessment of coronary flow reserve by sestamibi imaging in patients with typical chest pain and normal coronary arteries. Eur J Nucl Med Mol Imaging. 2007;34:1156-1.PubMed View Article
  18.Marini C, Giusti M, Armonino R, Ghigliotti G, Bezante G, Vera L, et al. Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2010;37:2256-3.PubMed View Article
  19.Daniele S, Nappi C, Acampa W, Storto G, Pellegrino T, Ricci F, et al. Incremental prognostic value of coronary flow reserve assessed with single-photon emission computed tomography. J Nucl Cardiol. 2011;18:612-.PubMed View Article
  20.Heymann MA, Payne BD, Hoffman JI, Rudolph AM. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis. 1977;20:55-9.PubMed View Article
  21.Petretta M, Soricelli A, Storto G, Cuocolo A. Assessment of coronary flow reserve using single photon emission computed tomography with technetium 99m-labeled tracers. J Nucl Cardiol. 2008;15:456-5.PubM
• 作者单位：Dimitris J. Apostolopoulos (1)
  Agaristi Kaspiri (1)
  Trifon Spyridonidis (1)
  Nikolaos Patsouras (2)
  Christos A. Savvopoulos (1)
  Pericles Davlouros (2)
  Pavlos. J. Vassilakos (1)
  Dimitrios Alexopoulos (2)
  
  1. Department of Nuclear Medicine, University Hospital of Patras, University of Patras, Medical School, 26504, Rion Patras, Greece
  2. Department of Cardiology, University Hospital of Patras, University of Patras, Medical School, 26504, Rion Patras, Greece
  
• 刊物主题：Nuclear Medicine; Imaging / Radiology;
• 出版者：Springer Japan
• ISSN：1864-6433

文摘

Objective Estimation of myocardial blood flow (MBF) and coronary flow reserve (CFR) by SPECT myocardial perfusion imaging (MPI) remains challenging. Our aim was to approximate MBF and CFR by quantifying the absolute Tc-99m tetrofosmin retention in the myocardium via gated-SPECT/CT MPI. Methods Tracer retention was calculated on the basis of the microsphere kinetic model and served as an index of MBF at stress and rest (sMBFi, rMBFi). CFR was given by the sMBFi/rMBFi ratio. A planar first-pass acquisition during dipyridamole stress and at rest provided the data for tracer input determination. The input was represented by the integral of a gamma variate fitted on the time-activity curve of the left ventricle. Gated-SPECT/CT was performed 1?h post tracer injection and myocardial activity was measured in attenuation-corrected transaxial slices by a threshold VOI. The input was also compensated for tissue attenuation by measuring the distance from the centre of the left ventricle to the body surface on fused SPECT/CT slices. Input and uptake results were adjusted for planar-SPECT counting geometry differences by the aid of a phantom experiment. Thirty-nine subjects with low probability of coronary artery disease (CAD), age lower than 75?years and normal MPI (control group) were compared with 57 patients with documented CAD (CAD group). Results CFR and sMBFi values of CAD patients (1.39?±?0.37 and 1.42?±?0.35?ml/min/g) were considerably lower (p?<?0.0001) than controls (1.68?±?0.25 and 1.72?±?0.37?ml/min/g). Significant difference in CFR (p?=?0.03) was also noted between CAD patients with normal MPI (1.48?±?0.38) and controls. However, sMBFi managed to discriminate certain CAD subgroups (normal MPI/ischemia/scar/scar and ischemia) more efficiently than CFR. Maximum heart rate-blood pressure product (RPP) during stress was an independent predictor of sMBFi and CFR. The other independent CFR correlates were resting RPP and diabetes mellitus, while sMBFi was associated with age, sex, smoking, and stress perfusion defects. Conclusions Despite the low myocardial extraction fraction of Tc-99m tetrofosmin, an approximation of MBF and CFR is feasible with gated-SPECT/CT MPI. These flow indices together were able to discriminate CAD patients from controls and stratify different patient subgroups.